UIC Diabetes Research Training Program

UIC糖尿病研究培训计划

• 批准号: 10206556
• 负责人: Terry G. Unterman
• 金额: $ 8.65万
• 依托单位: UNIVERSITY OF ILLINOIS AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-06-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10206556
• 关键词: Diabetes Mellitus; Research Training; Training Programs

Summary Diabetes mellitus is a major cause of morbidity and mortality in the United States and training the next generation of researchers is essential for developing new strategies to prevent and improve the treatment of diabetes. This T32 program will provide closely mentored, individualized, in-depth training in an interactive and supportive, multidisciplinary environment that fosters collaboration between disciplines and strongly promotes recruitment and retention of underrepresented minorities at the University of Illinois at Chicago (UIC). The largest university in the Chicago area with annual research expenditures of approximately $335 million, and recognized as a Minority and Hispanic Serving Institution, UIC provides outstanding opportunities for training in basic, clinical, translational, and behavioral and community-based research targeting diabetes and access to cutting edge technologies. PhD, MD and trainees in other clinical disciplines will be highly selected based on demonstrated research interest, accomplishments and potential, engagement in research, and the accomplishment of milestones (identification of research mentors, preparation of a preliminary project proposal and IDP) will be required prior to joining the T32 program. Individualized training and career development plans are developed at the outset with input from multidisciplinary mentoring teams that identify appropriate goals, needs and milestones. Trainees will receive training in grant writing, research integrity and ethics and methods to enhance research reproducibility, and participate in research seminars, journal clubs and work-in-progress meetings, and, when appropriate, complete graduate level courses pertinent to their research and career goals, including degree conferring programs at the Masters level (e.g. MS in Clinical and Translational Science, Health Informatics, etc). The development and submission of an individual NRSA or other career development application will be a major goal and training experience during the T32. The progress of trainees will be closely monitored and feedback from trainees on mentoring and the research program reviewed annually. Additional oversite and guidance will be provided by Internal and External Advisory Committees. The success of this program will be evaluated based on the research and academic success of its trainees. This program is designed to provide outstanding training in research related to diabetes in a vibrant, diverse and scientifically responsible environment at a major research institution in Chicago.

概括 糖尿病是美国发病率和死亡率的主要原因，培训 下一代研究人员对于制定预防和预防新战略至关重要 改善糖尿病的治疗。该 T32 计划将提供密切指导、 在互动和支持性的多学科环境中进行个性化的深入培训 促进学科之间的合作并大力促进招聘和保留 伊利诺伊大学芝加哥分校 (UIC) 的少数族裔代表性不足的问题。最大 芝加哥地区的大学，每年的研究支出约为 3.35 亿美元， UIC 被公认为少数族裔和西班牙裔服务机构，提供出色的服务 基础、临床、转化、行为和社区培训的机会 针对糖尿病的研究和尖端技术的获取。博士、医学博士和实习生 其他临床学科将根据表现出的研究兴趣进行精心选择， 成就和潜力、参与研究以及里程碑的实现 （确定研究导师、准备初步项目提案和 IDP） 在加入 T32 计划之前需要。个性化培训和职业发展 计划一开始就根据多学科指导团队的意见制定，这些指导团队确定了 适当的目标、需求和里程碑。学员将接受拨款写作、研究方面的培训 诚信和道德以及提高研究可重复性和参与研究的方法 研讨会、期刊俱乐部和正在进行的会议，并在适当时完成 与他们的研究和职业目标相关的研究生水平课程，包括学位授予 硕士学位课程（例如临床和转化科学、健康信息学、 ETC）。个人 NRSA 或其他职业发展的制定和提交 应用将是T32期间的主要目标和培训经验。学员的进步 将密切监测受训者对指导和研究计划的反馈 每年审查一次。内部和外部将提供额外的现场和指导 咨询委员会。该计划的成功将根据研究和结果进行评估 学员的学业成功。该计划旨在提供出色的培训 在充满活力、多样化和科学负责的环境中进行与糖尿病相关的研究 芝加哥的主要研究机构。